The U.S. Patent and Trademark Office has granted U.S. Patent No. 7,396,654 B2 "Neural Proteins as Biomarkers for Traumatic Brain Injury", licensed exclusively by Banyan Biomarkers from the University of Florida. Specifically, the patent covers the detection of certain neuronal protein markers found in the blood of patients suffering from neural injury and/or neuronal damage. The patent also covers certain sensitive and rapid methods and test kits that can be used as tools for the diagnosis of neural injuries and/or neuronal disorders such as brain injury, neural damage due to drug or alcohol addiction and diseases associated with the brain and central nervous system.

Banyan Biomarkers also holds the exclusive license from the University of Florida for U.S. Patent No. 7,291,710 "Detection of spectrin and spectrin proteolytic cleavage products in assessing nerve damage."

Gary Ascani, Chief Executive Officer of Banyan Biomarkers, Inc., commented, "Banyan continues to effectively build its intellectual portfolio and broaden our applications for biomarkers as critical tools for assisting physicians in diagnosing and managing patients with traumatic brain injuries and other acute central nervous system injuries such as stroke."